Advertisement

Lungenmetastasen

  • Marcus KrügerEmail author
  • Philipp Ivanyi
Living reference work entry
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Die Behandlung von Lungenmetastasen stellt eine interdisziplinäre Herausforderung dar. Für Lungenmetastasen der meisten Primärtumoren ist eine Therapie mit kurativer Intention nur durch eine chirurgische Resektion oder eine ablative nicht-operative Lokaltherapie möglich. Insbesondere durch die sich rasant entwickelnden Möglichkeiten der systemischen Therapieoptionen ändern sich die Voraussetzungen für die Indikationsstellung zur pulmonalen Metastasektomie in sehr kurzen Zeiträumen. Dieser Umstand führt neben ethischen Überlegungen dazu, dass die Generierung belastbarer Daten zur optimalen Behandlung von Lungenmetastasen kaum über randomisierte Studien abgebildet werden kann und die pulmonale Metastasektomie aus konzeptioneller Sicht auch perspektivisch kaum durch Daten hoher Evidenz validiert sein wird.

Literatur

  1. Agrawal A, Sahni S, Iftikhar A, Talwar A (2015) Pulmonary manifestation of renal carcinoma. Respir Med 109(12):1505–1508CrossRefGoogle Scholar
  2. Baldwin DR, Callister ME (2015) Guideline development group: the British thoracic society guidelines on the investigation and management of pulmonary nodules. Thorax 70(8):794–798CrossRefGoogle Scholar
  3. Boyer MJ, Ricardi U, Ball D, Salama JK (2016) Ablative approaches for pulmonary metastases. Thorac Surg Clin 26:19–34CrossRefGoogle Scholar
  4. Carballo M, Maish MS, Jaroszewski DE, Holmes CE (2009) Video-assisted thoracic surgery (VATS) as a safe alternative for the resection of pulmonary metastases: a retrospective cohort study. J Cardiothorac Surg 24(4):13CrossRefGoogle Scholar
  5. Dunn GP, Gavin P, Bruce AT et al (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3(11):991–998CrossRefGoogle Scholar
  6. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer, immunosurveillance and immunoediting. Immunity 21(2):137–148CrossRefGoogle Scholar
  7. Filderman AE, Coppage L, Shaw C, Matthay RA (1989) Pulmonary and pleural manifestations of extrathoracic malignancies. Clin Chest Med 10(4):747–807PubMedGoogle Scholar
  8. Fournel L, Maria S, Seminel M, Nesci J, Mansuet-Lupo A, Guinet C, Magdeleinat P, Bobbio A, Regnard JF, Alifano M (2017) Prognostic factors after pulmonary metastasectomy of colorectal cancers: a single-center experience. J Thorac Dis 9(Suppl 12):S1259–S1266CrossRefGoogle Scholar
  9. Franzke K, Natanov R, Zinne N, Rajab TK, Biancosino C, Zander I, Lodziewski S, Ricklefs M, Kropivnitskaya I, Schmitto JD, Haverich A, Krüger M (2017) Pulmonary metastasectomy – a retrospective comparison of surgical outcomes after laser-assisted and conventional resection. Eur J Surg Oncol 43(7):1357–1364CrossRefGoogle Scholar
  10. Gedik G, Kara P, Kara T, Sari O, Kara F (2010) Evaluation of FDG uptake in pulmonary hila with FDG PET/CT and contrast-enhanced CT in patients with thoracic and non-thoracic tumors. Ann Nucl Med 24(8):593–599CrossRefGoogle Scholar
  11. Gould M, Donington J, Lynch W, Mazzone P, Midthun D et al (2013) Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer (3. Aufl.) Amrican college of chest physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e93S–e120SCrossRefGoogle Scholar
  12. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 4(5):646–674CrossRefGoogle Scholar
  13. Hoerner-Rieber J, Duma M, Blanck O, Hildebrandt G, Wittig A, Lohaus F, Flentje M, Mantel F, Krempien R, Eble MJ, Kahl KH, Boda-Heggemann J, Rieken S, Guckenberger M (2017) Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group „Stereotactic Radiotherapy“. J Thorac Dis 9(11):4512–4522CrossRefGoogle Scholar
  14. Ike H, Shimada H, Ohki S, Togo S, Yamaguchi S, Ichikawa Y (2002) Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum 45(4):468–473CrossRefGoogle Scholar
  15. Inoue M, Ohta M, Iuchi K, Matsumura A, Ideguchi K, Yasumitsu T, Nakagawa K, Fukuhara K, Maeda H, Takeda S, Minami M, Ohno Y, Matsuda H (2004) Thoracic surgery study group of osaka university. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 78(1):238–244CrossRefGoogle Scholar
  16. Kaatsch P, Spix C, Katalinic A, et al (2015) Krebs in Deutschland 2011/2012. 10. Ausgabe. Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., BerlinGoogle Scholar
  17. Krüger M, Zinne N, Shin H, Zhang R, Biancosino C, Kropivnitskaja I, Länger F, Haverich A, Dettmer S (2016) Minimally invasive chest surgery. Is palpation control still necessary with modern computed tomography? Chirurg 87(2):136–143CrossRefGoogle Scholar
  18. Ma SJ, Mix M, Rivers C, Hennon M, Gomez J, Singh AK (2017) Mortality following single-fraction stereotactic body radiation therapy for central pulmonary oligometastasis. J Radiosurg SBRT 4(4):325–330PubMedPubMedCentralGoogle Scholar
  19. Marchioni A, Lasagni A, Cavazza A, Agostini L et al (2014) Endocronchial metastasis: an epidemiologic anc clinicopathologic study of 174 consecutive cases. Lung Cancer 84(3):222–228CrossRefGoogle Scholar
  20. Mitry E et al (2010) Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut 59:1383–1388CrossRefGoogle Scholar
  21. Ost D, Fein AM, Feinsilver SH (2003) Clinical practice. The solitary pulmonary nodule. N Engl J Med 348:2535CrossRefGoogle Scholar
  22. Pastorino U, Buyse M, Friedel G et al (1997) Long-term results of lung metastasectomy: prognostic analyses based an 5206 cases. J Thorac Cardiovasc Surg 113:37–49CrossRefGoogle Scholar
  23. Prasanna T, Briggs G, Jain S, Yip D (2018) Massive fatal pulmonary haemorrhage during bevacizumab treatment following microwave ablation therapy for oligometastatic lung metastasis from rectal cancer. Interact Cardiovasc Thorac Surg 26(3):514–515CrossRefGoogle Scholar
  24. Puchalski J (2017) Pulmonary manifestations of solid non-pulmonary malignancies. Clin Chest Med 38(2):177–186CrossRefGoogle Scholar
  25. Riquet M, Foucault C, Cazes A, Mitry E, Dujon A, Le Pimpec BF, Médioni J, Rougier P (2010) Pulmonary resection for metastases of colorectal adenocarcinoma. Ann Thorac Surg 89(2):375–380CrossRefGoogle Scholar
  26. Rusch VW (2008) Lung metastasis in Abeloff’s Clinical Oncology. Elsevier Health Sciences, PhiladelphiaGoogle Scholar
  27. Salah S, Watanabe K, Park JS, Addasi A, Park JW, Zabaleta J, Ardissone F, Kim J, Riquet M, Nojiri K, Gisabella M, Kim SY, Tanaka K (2013) Repeated resection of colorectal cancer pulmonary oligometastases: pooled analysis and prognostic assessment. Ann Surg Oncol 20(6):1955–1961CrossRefGoogle Scholar
  28. Schueller G, Herold C (2003) Lunge metastases. Cancer Imaging 3(2):126PubMedCentralGoogle Scholar
  29. Scott CD, Harpole DH (2016) The biology of pulmonary metastasis. Thorac Surg Clin 26:1–6CrossRefGoogle Scholar
  30. Sihag S, Muniappan A (2016) Lymph node dissection and pulmonary metastasectomy. Thorac Surg Clin 26(3):315–323CrossRefGoogle Scholar
  31. Sim Y, Goh Y, Dempsey M, Han S, Poon F (2013) PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology. Lung 191(6):625–632CrossRefGoogle Scholar
  32. Souzan N de, Liu Y, Chiti A, Oprea-Lager D, Gebhart G et al (2017) Strategies and technical challenges for imaging oligometastatic disease: recommendations from the European Organisation for Research and Treatment of Cancer imaging group. Eur J Cancer 38(2):177–186Google Scholar
  33. Thomford NR, Woolner LB, Clagett OT et al (1965) The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg 49:357–363PubMedGoogle Scholar
  34. Tsukamoto S, Kinugasa Y, Yamaguchi T, Shiomi A (2014) Survival after resection of liver and lung colorectal metastases in the era of modern multidisciplinary therapy. Int J Color Dis 29(1):81–87CrossRefGoogle Scholar
  35. Wagener C, Müller O (2010) Molekulare Onkolgie. Georg Thieme Verlag, Stuttgart, S 351 ffGoogle Scholar
  36. Watanabe K, Nagai K, Kobayashi A, Sugito M, Saito N (2009) Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. Br J Surg 96(9):1058–1065CrossRefGoogle Scholar
  37. Weinlechner J (1882) Tumoren an der Brust und deren Behandlung (Resektion der Rippen, Eroeffnung der Brusthoehle, partielle Entfernung der Lunge). Wien Med Wochenschr 590:20–21Google Scholar
  38. Whiteselle PL, Peters SG (1993) Pulmonary manifestations of extrathoracic malignant lesions. Mayo Clin Proc 68(5):483–491CrossRefGoogle Scholar
  39. Yasufuku K, Nakajima T, Motoori K, Sekine Y, Shibuya K et al (2006) Comparsion of endobonchial ultrasoudn, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 130(30):710–718CrossRefGoogle Scholar
  40. Ye T, Hu H, Luo X, Chen H (2011) The role of Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) fo qualitative diagnosis of medistinal and hilar lymphadenopathy: a prospective analysis. BMC Cancer 11(1):100CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Klinik für ThoraxchirurgieKrankenhaus Martha-Maria Halle-DölauHalleDeutschland
  2. 2.MHH, Klinik für Hämatologie, Onkologie, Hämostaseologie und StammzelltransplantationHannoverDeutschland

Section editors and affiliations

  • Claus Vogelmeier
    • 1
  1. 1.Klinik für Innere Medizin, Schwerpunkt PneumologieUniversitätsklinikum MarburgMarburgDeutschland

Personalised recommendations